**Question:** Aspirin inhibits which of the following enzymes?

A. Cyclooxygenase (COX)
B. Carbonic anhydrase
C. Serine proteases
D. Lipoxygenase

**Core Concept:**
Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), is known for its analgesic, anti-inflammatory, and antipyretic effects. The primary pharmacological action of aspirin is its inhibition of enzymes involved in the synthesis of prostaglandins, prostacyclins, and thromboxanes. The key target enzyme is Cyclooxygenase (COX), which has two isoforms: COX-1 and COX-2.

**Why the Correct Answer is Right:**
Aspirin exerts its effects by irreversibly inhibiting the COX enzymes, particularly COX-1 and to a lesser extent, COX-2. This inhibition leads to a decrease in the production of prostaglandins, which are involved in pain, inflammation, and fever responses.

**Why Each Wrong Option is Incorrect:**
A. COX-1 and COX-2 are the primary enzymes targeted by aspirin. Inhibition of these enzymes is responsible for the clinical effects of aspirin.

B. Carbonic anhydrase is an enzyme involved in regulating the balance of hydrogen ions (H+) and bicarbonate ions (HCO3-) in the body, particularly in the kidneys and the lens of the eye. Carbonic anhydrase inhibitors, such as acetazolamide, are used in treating glaucoma and edema. Aspirin does not target carbonic anhydrase, so this option is incorrect.

C. Serine proteases are involved in various physiological processes, including blood clotting, inflammation, and tissue repair. Aspirin does not inhibit serine proteases, making this option irrelevant to the pharmacological action of aspirin.

D. Lipoxygenase is another enzyme involved in prostaglandin synthesis, particularly in the production of leukotrienes. Although aspirin can inhibit lipoxygenase to some extent, its primary target is COX, making this option less relevant than COX.

**Clinical Pearl:**
Aspirin's inhibition of COX enzymes leads to the well-known antiplatelet and anti-inflammatory effects. Aspirin is commonly used in the prevention of cardiovascular events, such as stroke and myocardial infarction, by inhibiting platelet aggregation and reducing inflammation. This highlights the importance of understanding the pharmacology of aspirin and its targeted enzymes.